通过与α-synuclein的相互作用,GPNMB增加了帕金森病的风险
Maria E Diaz-Ortiz1,2, Yunji Seo1, Marijan Posavi1
1Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
概括
糖蛋白非转移性黑色素蛋白B (GPNMB) 是一种新发现的帕金森
科学领域:
- 神经科学
- 遗传学
- 生物化学
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了许多帕金森病 (PD) 风险位.
- 大多数PD风险位的特定基因和潜在机制在很大程度上是未知的.
研究的目的:
- 在染色体7的PD风险位点识别目标基因.
- 调查GPNMB在帕金森病发病过程中的作用.
主要方法:
- 对表达量特征位置 (eQTL) 和PD风险信号的局部化分析.
- 在人类大脑组织中进行基因特异表达研究.
- 在细胞模型中进行共免疫沉和同位测试.
- 诱导多能干细胞衍生神经元的研究.
- 对帕金森病患者和对照者的血GPNMB水平的分析.
主要成果:
- 由GWAS衍生的染色体7位点与GPNMB基因有关.
- 在细胞模型中发现GPNMB与α-synuclein (aSyn) 相互作用和同位.
- GPNMB的损失影响了aSyn纤维的内化和随后的神经元中的aSyn病理的发展.
- 在帕金森病患者的血中观察到高GPNMB水平,与疾病严重程度相关.
结论:
- GPNMB是一种新的帕金森病风险基因.
- 在aSyn病理中,GPNMB起着至关重要的作用.
- GPNMB有可能成为帕金森病的生物标志物和治疗点.
相关概念视频
Neural Regulation
39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Parkinson's Disease: Overview
684
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
684
Parkinson's Disease: Treatment
361
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
361


